BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6180585)

  • 1. Serum alpha-1-acid-glycoprotein, haptoglobin and C3 in Hodgkin's disease. A comparison with other acute-phase indicators.
    Gobbi PG; Merlini G; Parrinello GA; Cavalli P; Ascari E
    Acta Haematol; 1982; 67(4):255-62. PubMed ID: 6180585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of some humoral and cytological indices in active stages of Hodgkin's disease].
    Barbui T; Dini E; Chisesi T; Corà R; Franchi F; Cazzavillan M; Battista R
    Haematologica; 1972; 57(9):488-92. PubMed ID: 4125445
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serum ferritin and other biological parameters as indicators of tumor activity in Hodgkin's disease].
    Hermosa V; Mazo E; Baró J; Castillo E; Cordovilla JJ; Carril J; Zubizarreta A
    Sangre (Barc); 1985; 30(2):154-8. PubMed ID: 2409612
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
    Asbjörnsen G
    Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of copper, haptoglobin and alpha-2-globulin in the serum of patients with Hodgkin's disease].
    Cepelja Z; Grgić Z; Markinković M; Ivanov D
    Lijec Vjesn; 1975 May; 97(5):289-93. PubMed ID: 54857
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of some acute phase reactant proteins during phlogosis and neoplasms and their correlation with erythrocyte sedimentation rate].
    Triolo L; Mian G; Magris D; L'Abbate M; Tommasini T
    Arch Sci Med (Torino); 1979; 136(4):555-60. PubMed ID: 95158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reference values of IgA, IgG, IgM, alpha2-macroglobulin, alpha-1- antitrypsin, complement C3, complement C4, ceruloplasmin, haptoglobin, properdin factor B, acid alpha-1 glycoprotein and transferrin concentration in the blood of healthy children].
    Liappis N; Rossmöller M; Dörner K; Hildenbrand G
    Klin Padiatr; 1983 Mar; 195(2):107-16. PubMed ID: 6190038
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twelve serum protein profiles in children with acute nonbacterial gastroenterocolitis.
    Wiermannová D; Wiedermann D; Kadlcáková E
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(1):73-82. PubMed ID: 82577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma iron and copper in Hodgkin's disease. A comparison with other laboratory indicators.
    Gobbi PG; Scarpellini M; Minoia C; Pozzoli L; Perugini S
    Haematologica; 1979 Aug; 64(4):416-32. PubMed ID: 121577
    [No Abstract]   [Full Text] [Related]  

  • 11. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of metabolic parameters in Hodgkin's disease (author's transl)].
    Oertel J; Gerhartz H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jun; 86(2):185-93. PubMed ID: 59479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential changes in the concentration of specific serum proteins during typhoid fever infection in man.
    Bostian KA; Blackburn BS; Wannemacher RW; McGann VG; Beisel WR; Dupont HL
    J Lab Clin Med; 1976 Apr; 87(4):577-85. PubMed ID: 58049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's disease.
    Wagener DJ; Haanen C
    Eur J Clin Invest; 1977 Aug; 7(4):289-94. PubMed ID: 408150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin, C3 complement, haptoglobin, plasminogen and alpha 2-microglobulin in patients with urogenital tumors.
    Dunzendorfer U; Jung K; Ohlenschläger G
    Eur Urol; 1980; 6(4):232-6. PubMed ID: 6156074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
    Wilimas J; Thompson E; Smith KL
    Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute-phase-proteins and parameters of humoral immunity in patients with advanced Hodgkin's disease.
    Zielinski CC; Preis P; Aiginger P; Eibl MM
    J Cancer Res Clin Oncol; 1985; 110(1):65-70. PubMed ID: 2410428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor markers in renal cell carcinoma].
    Uchida T; Shinohara K; Kobayashi K; Honda N; Ao T; Omata T; Odajima K; Koshiba K
    Hinyokika Kiyo; 1986 Jul; 32(7):929-40. PubMed ID: 3776772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in serum acute phase proteins in breast cancer patients receiving methotrexate infusion therapy.
    Fish RG; Yap AK; James K
    Clin Biochem; 1982 Feb; 15(1):4-8. PubMed ID: 6175443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Measurement of inflammatory activity in chronic rheumatism by blood pretein levels].
    Chalès G; Pawlotsky Y; Le Treut A; Catheline M; Le Gall JY; Cloarec L
    Rev Rhum Mal Osteoartic; 1980; 47(7-9):493-9. PubMed ID: 6158755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.